PIK3CA and acute lymphoblastic leukemia: We report the clinical course and outcomes of five patients suffering from refractory or relapse (R/R) T-ALL or T-LL (T-ALL/LL) harboring PI3K-altered and treated with the association erwinase and temsirolimus (ET).